Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study

被引:0
|
作者
S Friis
A Poulsen
L Pedersen
J A Baron
H T Sørensen
机构
[1] Institute of Cancer Epidemiology,Department of Genetics and Medicine
[2] Danish Cancer Society,Department of Clinical Epidemiology
[3] Aarhus University Hospital,Departments of Medicine and Community and Family Medicine
[4] Dartmouth Medical School,undefined
[5] Dartmouth College,undefined
来源
British Journal of Cancer | 2006年 / 95卷
关键词
nonsteroidal anti-inflammatory drugs; oral cancer; population based; risk; cohort study;
D O I
暂无
中图分类号
学科分类号
摘要
Epidemiologic data regarding the chemopreventive potential of nonsteroidal anti-inflammatory drugs (NSAIDs) against oral cancer are sparse. We found a relative risk for oral cancer of 1.2 (95% CI, 1.0–1.6) among 169 589 Danish NSAID users (⩾2 prescriptions), with no apparent trends in subgroups. Our study provided no clear evidence that NSAIDs may protect against oral cancer.
引用
收藏
页码:363 / 365
页数:2
相关论文
共 50 条
  • [11] Nonsteroidal anti-inflammatory drugs and the risk of skin cancer
    Johannesdottir, Sigrun Alba
    Chang, Ellen T.
    Mehnert, Frank
    Schmidt, Morten
    Olesen, Anne Braae
    Sorensen, Henrik Toft
    CANCER, 2012, 118 (19) : 4768 - 4776
  • [12] Nonsteroidal anti-inflammatory drugs and risk of lung cancer
    Hernandez-Diaz, Sonia
    Garcia Rodriguez, Luis A.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) : 1565 - 1572
  • [14] Use of nonsteroidal anti-inflammatory drugs and risk of endometrial cancer: a nationwide case–control study
    Nanna Brøns
    Louise Baandrup
    Christian Dehlendorff
    Susanne K. Kjaer
    Cancer Causes & Control, 2015, 26 : 973 - 981
  • [15] Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study
    Cairat, Manon
    Fournier, Agnes
    Murphy, Neil
    Biessy, Carine
    Scalbert, Augustin
    Rinaldi, Sabina
    Tjonneland, Anne
    Olsen, Anja
    Overvad, Kim
    Arveux, Patrick
    Boutron-Ruault, Marie-Christine
    Cadeau, Claire
    Fortner, Renee Turzanski
    Kaaks, Rudolf
    Boeing, Heiner
    Aleksandrova, Krasimira
    Peeters, Petra H. M.
    Van Gils, Carla H.
    Wareham, Nicholas J.
    Khaw, Kay-Tee
    Aune, Dagfinn
    Riboli, Elio
    Gunter, Marc J.
    Dossus, Laure
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (07) : 1688 - 1695
  • [16] Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort
    Brasky, Theodore M.
    Velicer, Christine M.
    Kristal, Alan R.
    Peters, Ulrike
    Potter, John D.
    White, Emily
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (12) : 3185 - 3188
  • [17] Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer
    Reinau, Daphne
    Surber, Christian
    Jick, Susan S.
    Meier, Christoph R.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (01) : 144 - 153
  • [18] Modulation of Breast Cancer Risk by Nonsteroidal Anti-inflammatory Drugs
    Howe, Louise R.
    Lippman, Scott M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (20): : 1420 - 1423
  • [19] Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
    Lindblad, M
    Lagergren, J
    Rodríguez, LAG
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) : 444 - 450
  • [20] Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults
    Derry, Sheena
    Wiffen, Philip J.
    Moore, R. Andrew
    McNicol, Ewan D.
    Bell, Rae F.
    Carr, Daniel B.
    McIntyre, Mairead
    Wee, Bee
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (07):